J&J Contests FDA-Proposed Cap With Study Championing High SPF Sunscreens

Johnson & Johnson is strengthening its stance against FDA's proposed maximum for sun protection factors on sunscreen products with a new study refuting the notion that high SPF formulas cannot be accurately and consistently measured.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight